Literature DB >> 33059529

Mortality in the USA, the UK and Other Western Countries, 1989-2015: What Is Wrong With the US?

Colin Pritchard1, Sam Porters1, Emily Rosenorn-Lanng1, Richard Williams1.   

Abstract

This population-based study compares U.S. effectiveness with 20 Other Western Countries (OWC) in reducing mortality 1989-1991 and 2013-2015 and, responding to criticisms of Britain's National Health Service, directly compares U.S. with U.K. child (0-4), adult (55-74), and 24 global mortality categories. World Health Organization Age-Standardized Death Rates (ASDR) data are used to compare American and OWC mortality over the period, juxtaposed against national average percentages of Gross Domestic Product (GDP) Expenditure on Health (%GDPEH) drawn from World Bank data. America's average %GDPEH was highest at 13.53% and Britain's the lowest at 7.68%. Every OWC had significantly greater ASDR reductions than America. Current U.S. child and adult mortality rates are 46% and 19% higher than Britain's. Of 24 global diagnostic mortalities, America had 16 higher rates than Britain, notably for Circulatory Disease (24%), Endocrine Disorders (70%), External Deaths (53%), Genitourinary (44%), Infectious Disease (65%), and Perinatal Deaths (34%). Conversely, U.S. rates were lower than Britain's for Neoplasms (11%), Respiratory (12%), and Digestive Disorder Deaths (11%). However, had America matched the United Kingdom's ASDR, there would have been 488,453 fewer U.S. deaths. In view of American %GDPHE and their mortality rates, which were significantly higher than those of the OWC, these results suggests that the U.S. health care system is the least efficient in the Western world.

Entities:  

Keywords:  USA; Western world; comparison; expenditure; health; international; mortality

Year:  2020        PMID: 33059529      PMCID: PMC7756066          DOI: 10.1177/0020731420965130

Source DB:  PubMed          Journal:  Int J Health Serv        ISSN: 0020-7314            Impact factor:   1.663


  30 in total

1.  The Current and Projected Taxpayer Shares of US Health Costs.

Authors:  David U Himmelstein; Steffie Woolhandler
Journal:  Am J Public Health       Date:  2016-01-21       Impact factor: 9.308

2.  Modelling suicide and unemployment: a longitudinal analysis covering 63 countries, 2000-11.

Authors:  Carlos Nordt; Ingeborg Warnke; Erich Seifritz; Wolfram Kawohl
Journal:  Lancet Psychiatry       Date:  2015-02-25       Impact factor: 27.083

3.  Obesity as a risk factor for developing functional limitation among older adults: A conditional inference tree analysis.

Authors:  Feon W Cheng; Xiang Gao; Le Bao; Diane C Mitchell; Craig Wood; Martin J Sliwinski; Helen Smiciklas-Wright; Christopher D Still; David D K Rolston; Gordon L Jensen
Journal:  Obesity (Silver Spring)       Date:  2017-05-24       Impact factor: 5.002

4.  Health Care Administrative Costs in the United States and Canada, 2017.

Authors:  David U Himmelstein; Terry Campbell; Steffie Woolhandler
Journal:  Ann Intern Med       Date:  2020-01-07       Impact factor: 25.391

5.  Coverage Expansions and Utilization of Physician Care: Evidence From the 2014 Affordable Care Act and 1966 Medicare/Medicaid Expansions.

Authors:  Adam Gaffney; Danny McCormick; David Bor; Steffie Woolhandler; David Himmelstein
Journal:  Am J Public Health       Date:  2019-10-17       Impact factor: 9.308

6.  Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of the EUROCARE-4 study.

Authors:  Franco Berrino; Roberta De Angelis; Milena Sant; Stefano Rosso; Magdalena Bielska-Lasota; Magdalena B Lasota; Jan W Coebergh; Mariano Santaquilani
Journal:  Lancet Oncol       Date:  2007-09       Impact factor: 41.316

7.  Economic Hardship in Childhood: A Neglected Issue in ACE Studies?

Authors:  Paula Braveman; Katherine Heck; Susan Egerter; Christine Rinki; Kristen Marchi; Mike Curtis
Journal:  Matern Child Health J       Date:  2018-03

8.  Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data.

Authors:  M P Coleman; D Forman; H Bryant; J Butler; B Rachet; C Maringe; U Nur; E Tracey; M Coory; J Hatcher; C E McGahan; D Turner; L Marrett; M L Gjerstorff; T B Johannesen; J Adolfsson; M Lambe; G Lawrence; D Meechan; E J Morris; R Middleton; J Steward; M A Richards
Journal:  Lancet       Date:  2010-12-21       Impact factor: 79.321

9.  Comparing cancer mortality and GDP health expenditure in England and Wales with other major developed countries from 1979 to 2006.

Authors:  C Pritchard; T Hickish
Journal:  Br J Cancer       Date:  2011-10-04       Impact factor: 7.640

10.  A longitudinal ecological study of household firearm ownership and firearm-related deaths in the United States from 1999 through 2014: A specific focus on gender, race, and geographic variables.

Authors:  David A Geier; Janet K Kern; Mark R Geier
Journal:  Prev Med Rep       Date:  2017-04-12
View more
  2 in total

1.  Examining the Economic Perspective of Treatable Mortality: The Role of Health Care Financing and the Importance for Economic Prosperity.

Authors:  Viera Ivankova; Beata Gavurova; Samer Khouri; Gabriel Szabo
Journal:  Front Public Health       Date:  2021-12-13

2.  Can ENGLAND'S National Health System Reforms Overcome the Neoliberal Legacy?

Authors:  Kate Bayliss
Journal:  Int J Health Serv       Date:  2022-07-26       Impact factor: 1.851

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.